|
RTN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.5637999999989E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74317999999118E-05 |
| Normal-vs-Stage2 |
1.208320E-02 |
| Normal-vs-Stage3 |
1.025760E-01 |
| Normal-vs-Stage4 |
5.565800E-01 |
| Stage1-vs-Stage2 |
2.782800E-01 |
| Stage1-vs-Stage3 |
3.052000E-02 |
| Stage1-vs-Stage4 |
6.228200E-02 |
| Stage2-vs-Stage3 |
4.817200E-01 |
| Stage2-vs-Stage4 |
3.648200E-01 |
| Stage3-vs-Stage4 |
7.114800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.11630000000507E-05 |
| Normal-vs-AfricanAmerican |
1.596910E-03 |
| Normal-vs-Asian |
4.524200E-01 |
| Caucasian-vs-AfricanAmerican |
4.187000E-01 |
| Caucasian-vs-Asian |
4.939200E-01 |
| AfricanAmerican-vs-Asian |
6.846600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.99129999997905E-07 |
| Normal-vs-Female |
5.697800E-02 |
| Male-vs-Female |
8.37479999999946E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.063480E-03 |
| Normal-vs-Extreme_Weight |
1.15220000207472E-08 |
| Normal-vs-Obese |
3.299400E-03 |
| Normal-vs-Extreme_Obese |
2.440000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.715400E-01 |
| Normal_Weight-vs-Obese |
4.939600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.003600E-01 |
| Extreme_Weight-vs-Obese |
4.058300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.500810E-01 |
| Obese-vs-Extreme_Obese |
5.430600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.399370E-01 |
| Normal-vs-Age(41-60Yrs) |
8.234400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.13049999999715E-05 |
| Normal-vs-Age(81-100Yrs) |
3.555500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.069200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.241570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.379800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.116170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.198000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.361600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.78449999946417E-07 |
| Normal-VS-Type2 PRCC |
7.318500E-03 |
| Normal-VS-KIRP CIMP |
1.308280E-02 |
| Normal-VS-Unclassified PRCC |
2.849500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.376000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.88000000012067E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
5.691800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.415900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.493600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.64250999999949E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54793000000097E-05 |
| Normal-vs-N1 |
5.030400E-01 |
| Normal-vs-N2 |
5.476800E-01 |
| N0-vs-N1 |
4.484200E-03 |
| N0-vs-N2 |
1.505890E-02 |
| N1-vs-N2 |
4.749200E-01 |
|
|
